Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6232 of 6351
-
Healthy volunteers help unravel drug interaction mystery
Knowledge-focused CompletedThe goal of this study is to learn how belzutifan (MK-6482) affects the levels of metformin in a healthy person's body over time. Researchers will study levels of metformin in the blood and urine in healthy volunteers after taking metformin alone (Period 1) and metformin with bel…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Mitopure skin patches pass safety check in 113 volunteers
Knowledge-focused CompletedThe objective of this study is to investigate the irritation and sensitization potential of 6 different topically applied test articles containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modif…
Sponsor: Amazentis SA • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New drug IMC-003 put to the test in healthy women – no cure expected
Knowledge-focused Recruiting nowthis study is a randomized, double-blind, placebo-controlled, single and multiple dose escalation Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of IMC-003 for injection in healthy postmenopausal women.
Phase 1 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New drug JADE101 tested in healthy people for first time
Knowledge-focused OngoingThis is a Phase 1, first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE101 compared to placebo in healthy participants.
Phase 1 • Sponsor: Jade Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Promising combo for resistant colon cancer never gets off the ground
Disease control CancelledBackground: Metastatic colorectal cancer (mCRC) is cancer that has spread beyond the colon and rectum. Most people with mCRC die within 5 years. New immune-based treatments are making progress with some types of colon cancer. But these treatments do little for people with a type…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Parkinson's study probes blood Pressure's role in brain function
Knowledge-focused CancelledThe goal of clinical trial is to learn about how blood pressure fluctuations affect cognitive performance (thinking abilities) and brain blood flow in persons with Parkinson's disease with and without orthostatic hypotension (low blood pressure when standing). The main questions …
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New prosthetic control system put to the test in short study
Knowledge-focused CancelledThis study tests how well the Phantom X prosthesis control system works. The system helps control a prosthetic hand using muscle signals from the arm. You'll wear a non-invasive version for one day in the clinic. You'll practice hand movements and then do two simple tasks with bo…
Sponsor: Phantom Neuro Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Paxlovid copycat pills put to the test – but study pulled
Knowledge-focused CancelledMedicines that may have different names or be made in different ways but have the same effect on the body are called bioequivalent. The purpose of this study is to learn about the bioequivalence of nirmatrelvir plus ritonavir after taking 2 different combination tablet forms by …
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
App aims to help parents of kids with diabetes, but study was withdrawn
Knowledge-focused CancelledThis study aims to identify the unmet psychoeducational needs of parents of children 8-12 years of age using insulin pump and CGM for pediatric T1D management and to leverage that information to develop an innovative app-based psychoeducational intervention to optimize use of the…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Pfizer checks if new atirmociclib tablet matches the old one
Knowledge-focused CompletedThe purpose of this study is to understand bioequivalence (medicines that may have different names or be made in different ways, but have the same effect on the body) of the current PF-07220060 tablet formulation and the proposed higher drug load tablet that is already available …
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Withdrawn study sought to ease lymphedema fears in breast cancer patients
Knowledge-focused CancelledThis clinical trial assesses the change in lymphatic structure from placement of an intravenous (IV) line and fluid administration using a diagnostic agent, indocyanine green (ICG), with SPY (Trademark) angiography in breast cancer patients at risk for breast cancer-related lymph…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:41 UTC
-
Eczema cream study halted after just 3 volunteers
Symptom relief Stopped earlyThis is a research study. The over-the-counter (OTC) drug for atopic dermatitis being tested is not approved as a treatment for the participants' atopic dermatitis condition. In participating in this study, the investigators will analyze the participants' skin microbiome, measure…
Phase 1 • Sponsor: Good Molecules, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Cancer combo trial pulled before it even started
Disease control CancelledThis is a phase Ib/II, randomized, open-label, multicenter clinical trial to evaluate the antitumor activities, safety, tolerability and pharmacokinetics (PK) of IN10018 in combination with taxane and anti-PD-1/L1 monoclonal antibody in patients with locally advanced or metastati…
Phase 1/2 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New siRNA drug ADX-626 tested in humans for first time
Knowledge-focused Recruiting nowThis first-in-human study will evaluate the safety and tolerability of ADX-626 in healthy participants. The study will also look at how ADX-626 interacts with the human body (the pharmacokinetics and pharmacodynamics of ADX-626).
Phase 1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Ear tickling reveals brain secrets in healthy volunteers
Knowledge-focused Recruiting nowThis is a single-visit non-invasive study of healthy volunteer subjects. Brain activity will be measured with infra-red light sensors attached to a cap worn on the head, while both ears are gently stimulated with plastic filaments.
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New drug ZKLJ02 tested for safety in 50 healthy chinese adults
Knowledge-focused CompletedA randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single intravenous administration of ZKLJ02 injection in healthy Chinese research participants
Phase 1 • Sponsor: Yunnan Zhongke Longjin Biotechnology Co.,Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New drug LY3985863 tested for safety in healthy volunteers
Knowledge-focused CompletedThe purpose of this study is to evaluate how well LY3985863 is tolerated and what side effects may occur in healthy Chinese participants. The study drug will be administered subcutaneously (SC) (under the skin). Blood tests will be performed to investigate how the body processes…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Tiny trial tests new injectable implant in just 2 volunteers
Knowledge-focused PausedThe goal of this clinical trial is to evaluate the safety of implanting a new medical device (Fractomer™ Biomatrix) in healthy volunteers. The main question it aims to answer is: How do healthy volunteers react to this injectable implant? Participants will receive a subcutaneou…
Sponsor: inSoma Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Healthy volunteers needed to test drug interaction in new study
Knowledge-focused By invitation onlyThis is a single-center, open-label, two-period, fixed-sequence clinical study to evaluate the effect of Itraconazole on the pharmacokinetics of HSK31858 in healthy subjects
Phase 1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Healthy volunteers needed to test safety of experimental drug budoprutug
Knowledge-focused CompletedThe main objective is to assess the safety and tolerability of subcutaneous and intravenous injection forms of budoprutug in healthy volunteers.
Early phase 1 • Sponsor: Climb Bio, Inc. • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC